Phage as a modulator of immune responses: practical implications for phage therapy.

[1]  M. Slifka,et al.  Contributions of humoral and cellular immunity to vaccine-induced protection in humans. , 2011, Virology.

[2]  N. Tsao,et al.  Experimental Phage Therapy in Treating Klebsiella pneumoniae-Mediated Liver Abscesses and Bacteremia in Mice , 2011, Antimicrobial Agents and Chemotherapy.

[3]  G. Korczak-Kowalska,et al.  The effects of T4 and A3/R phage preparations on whole-blood monocyte and neutrophil respiratory burst. , 2010, Viral immunology.

[4]  M. Rossmann,et al.  Functional analysis of the highly antigenic outer capsid protein, Hoc, a virus decoration protein from T4‐like bacteriophages , 2010, Molecular microbiology.

[5]  S. Chhibber,et al.  Evidence to support the therapeutic potential of bacteriophage Kpn5 in burn wound infection caused by Klebsiella pneumoniae in BALB/c mice. , 2010, Journal of microbiology and biotechnology.

[6]  Manuel T. Silva.  When two is better than one: macrophages and neutrophils work in concert in innate immunity as complementary and cooperative partners of a myeloid phagocyte system , 2010, Journal of leukocyte biology.

[7]  Himanshu Kumar,et al.  Toll-like receptors and innate immunity. , 2009, Biochemical and biophysical research communications.

[8]  D. Forthal,et al.  Fc receptor-mediated antiviral antibodies , 2009, Current opinion in HIV and AIDS.

[9]  M. Zimecki,et al.  Effects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus , 2009, BMC Microbiology.

[10]  C. Kamme,et al.  Antibodies against staphylococcal bacteriophages in human sera. I. Assay of antibodies in healthy individuals and in patients with staphylococcal infections. , 2009, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology.

[11]  R. Chess-Williams,et al.  Blood kinetics of four intraperitoneally administered therapeutic candidate bacteriophages in healthy and neutropenic mice , 2009, Microbiology and immunology.

[12]  W. Fortuna,et al.  A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses , 2009, Clinical and Experimental Medicine.

[13]  J. Borysowski,et al.  Is phage therapy acceptable in the immunocompromised host? , 2008, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[14]  H. Krisch,et al.  The immense journey of bacteriophage T4--from d'Hérelle to Delbrück and then to Darwin and beyond. , 2008, Research in microbiology.

[15]  W. Hardt,et al.  PEGylation of bacteriophages increases blood circulation time and reduces T‐helper type 1 immune response , 2008, Microbial biotechnology.

[16]  W. Fortuna,et al.  Bacteriophage preparation inhibition of reactive oxygen species generation by endotoxin-stimulated polymorphonuclear leukocytes. , 2008, Virus research.

[17]  M. Zembala,et al.  Hoc protein regulates the biological effects of T4 phage in mammals , 2007, Archives of Microbiology.

[18]  Zhou Yu,et al.  Ig-like domains on bacteriophages: a tale of promiscuity and deceit. , 2006, Journal of molecular biology.

[19]  A. Górski,et al.  Possible association between phages, Hoc protein, and the immune system , 2006, Archives of Virology.

[20]  M. Zimecki,et al.  Effects of bacteriophages on free radical production and phagocytic functions , 2006, Medical Microbiology and Immunology.

[21]  C. Merril,et al.  An amino acid substitution in a capsid protein enhances phage survival in mouse circulatory system more than a 1000-fold. , 2005, Virus research.

[22]  H. Brüssow,et al.  Human Volunteers Receiving Escherichia coli Phage T4 Orally: a Safety Test of Phage Therapy , 2005, Antimicrobial Agents and Chemotherapy.

[23]  A. Górski,et al.  The potential role of endogenous bacteriophages in controlling invading pathogens , 2005, Cellular and Molecular Life Sciences.

[24]  H. Ochs,et al.  Rituximab Inhibits the In Vivo Primary and Secondary Antibody Response to a Neoantigen, Bacteriophage phiX174 , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  A. Sulakvelidze,et al.  Phage Therapy in Animals and Agribusiness , 2004 .

[26]  Jason R. Clark,et al.  Bacterial viruses as human vaccines? , 2004, Expert review of vaccines.

[27]  M. De la Fuente,et al.  Immune cells: free radicals and antioxidants in sepsis. , 2004, International immunopharmacology.

[28]  M. Zimecki,et al.  Effect of phage therapy on the turnover and function of peripheral neutrophils. , 2002, FEMS immunology and medical microbiology.

[29]  A. Górski,et al.  Enhanced T cells interactions with extracellular matrix proteins in infertile women with endometriosis. , 2002, Immunology letters.

[30]  T. V. van Berkel,et al.  Uptake and processing of modified bacteriophage M13 in mice: implications for phage display. , 2002, Virology.

[31]  J. Wolff,et al.  The interactions of peptides with the innate immune system studied with use of T7 phage peptide display. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[32]  F. Felici,et al.  Uptake and intracellular fate of phage display vectors in mammalian cells. , 1999, Biochimica et biophysica acta.

[33]  I. Bernstein,et al.  Normal immunologic response to a neoantigen, bacteriophage phiX-174, in baboons with long-term lymphohematopoietic reconstitution from highly purified CD34+ Lin- allogeneic marrow cells. , 1997, Blood.

[34]  A. Meola,et al.  Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration. , 1997, Vaccine.

[35]  S. Adamu,et al.  The effect of Staphylococcus aureus phage lysate vaccine on a rabbit model of staphylococcal blepharitis, phlyctenulosis, and catarrhal infiltrates. , 1996, American journal of ophthalmology.

[36]  C. Merril,et al.  Long-circulating bacteriophage as antibacterial agents. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[37]  L. Lebeck,et al.  Rapid flow cytometric assay for the assessment of natural killer cell activity. , 1993, Journal of immunological methods.

[38]  L. Borish,et al.  Asthmatic patients have neutrophils that exhibit diminished responsiveness to adenosine. , 1989, The American review of respiratory disease.

[39]  N. Shinomiya,et al.  [Effects of staphylococcal phage lysate (SPL) on immunoglobulin production in human peripheral lymphocyte cultures]. , 1985, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[40]  Bogden Ae,et al.  The concept of induction and elicitation as an immunotherapeutic approach. , 1978 .

[41]  R. Arnon,et al.  Cellular immune response toward MS-2 phage and a synthetic fragment of its coat protein. , 1978, Cellular immunology.

[42]  R. Connor,et al.  The relative proliferation index as a more sensitive parameter for evaluating lymphoproliferative responses of cancer patients to mitogens and alloantigens , 1977, International journal of cancer.

[43]  M. Yanagida,et al.  The two dispensable structural proteins (soc and hoc) of the T4 phage capsid; their purification and properties, isolation and characterization of the defective mutants, and their binding with the defective heads in vitro. , 1977, Journal of molecular biology.

[44]  Bespalova Ia,et al.  Electron-microscopic study of the serological affinity between the antigenic components of phages T4 and DDVI. , 1976 .

[45]  R. Herberman,et al.  In vitro human reactivity to staphylococcal phage lysate. , 1975, Journal of immunology.

[46]  E. Mankiewicz,et al.  The effect of mycobacteriophage particles on cell-mediated immune reactions. , 1974, Canadian journal of microbiology.

[47]  C. Merril,et al.  Fate of Bacteriophage Lambda in Non-immune Germ-free Mice , 1973, Nature.

[48]  M. Yanagida.  Identification of some antigenic precursors of bacteriophage T4. , 1972, Journal of molecular biology.

[49]  H. Ochs,et al.  Immunologic responses to bacteriophage phi-X 174 in immunodeficiency diseases. , 1971, The Journal of clinical investigation.

[50]  R. J. Douthart,et al.  Interferon Production by T4 Coliphage , 1970, Nature.

[51]  J. Michael,et al.  Contribution of Endotoxin to Antibody Formation against T2 Phage , 1969, Nature.

[52]  A. Shahar,et al.  ELECTRON MICROSCOPY OF IN VITRO ENDOCYTOSIS OF T2 PHAGE BY CELLS FROM RABBIT PERITONEAL EXUDATE , 1964, The Journal of experimental medicine.

[53]  M. Symonds,et al.  STAPHAGE LYSATE THERAPY IN CHRONIC STAPHYLOCOCCAL INFECTIONS. , 1963, The Journal of the Medical Society of New Jersey.

[54]  Baker Ag.  Staphyloccus bacteriophage lysate: topical and parenteral use in allergic patients. , 1963 .

[55]  A. E. Mills.  Staphylococcus phage lysates: An immuno‐biological therapy for the prevention and control of staphylococcal disease , 1962, The Laryngoscope.

[56]  Z. Wieczorek,et al.  In vitro blockade of bacterial phagocytosis of leukocytes by means of bacterial viruses. , 1958, Schweizerische Zeitschrift fur Pathologie und Bakteriologie. Revue suisse de pathologie et de bacteriologie.

[57]  A. E. Mills.  Staphylococcus bacteriophage lysate aerosol therapy of sinusitis , 1956, The Laryngoscope.

[58]  N. K. Jerne,et al.  The development of the phage-inactivating properties of serum during the course of specific immunization of an animal: reversible and irreversible inactivation. , 1956, Journal of immunology.

[59]  N. K. Jerne,et al.  The presence in normal serum of specific antibody against bacteriophage T4 and its increase during the earliest stages of immunization. , 1956, Journal of immunology.

[60]  F. D. Herelle,et al.  The Bacteriophage, Its Role in Immunity , 1923, The Indian Medical Gazette.

[61]  W. Gorczyca,et al.  Bacteriophages and transplantation tolerance. , 2006, Transplantation proceedings.

[62]  A. Górski,et al.  Antitumor activity of bacteriophages in murine experimental cancer models caused possibly by inhibition of beta3 integrin signaling pathway. , 2004, Acta virologica.

[63]  A. Srivastava,et al.  Immunological factors that affect the in vivo fate of T7 phage in the mouse. , 2004, Journal of virological methods.

[64]  S. Eddy,et al.  A Member of the Immunoglobulin Superfamily in Bacteriophage T4 , 2004, Virus Genes.

[65]  M. Zimecki,et al.  Bacteriophages provide regulatory signals in mitogen-induced murine splenocyte proliferation. , 2003, Cellular & molecular biology letters.

[66]  M. Zimecki,et al.  Effective phage therapy is associated with normalization of cytokine production by blood cell cultures. , 2000, Archivum immunologiae et therapiae experimentalis.

[67]  A. Górski,et al.  Bacteriophage therapy of bacterial infections: an update of our institute's experience. , 2000, Archivum immunologiae et therapiae experimentalis.

[68]  K. Schwarz,et al.  Oxidative stress during viral infection: a review. , 1996, Free radical biology & medicine.

[69]  A. Mileo,et al.  Polymorphonuclear leukocyte stimulation measured by phage inactivation. , 1989, International archives of allergy and applied immunology.

[70]  S. Ramasastry,et al.  Immunomodulation of intradermal mammary carcinoma using staphage lysate in a rat model. , 1988, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[71]  M. Dabrowski,et al.  Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986. , 1987, Archivum immunologiae et therapiae experimentalis.

[72]  A. Kucharewicz-Krukowska,et al.  Immunogenic effect of bacteriophage in patients subjected to phage therapy. , 1987, Archivum immunologiae et therapiae experimentalis.

[73]  A. Bogdén,et al.  Specific and nonspecific immune resistance enhancing activity of staphage lysate. , 1981, Journal of immunopharmacology.

[74]  H. Ochs,et al.  The recognition and classification of immunodeficiency diseases with bacteriophage phiChi 174. , 1975, Birth defects original article series.

[75]  C. Inchley.  The actvity of mouse Kupffer cells following intravenous injection of T4 bacteriophage. , 1969, Clinical and experimental immunology.

[76]  Y. Chang,et al.  Studies on phagocytosis: I. Uptake of radio-iodinated (131I) human serum albumin as a measure of the degree of phagocytosis in vitro , 1969 .

[77]  G. Stent.  Molecular Biology of Bacterial Viruses , 1963 .

[78]  M. Kańtoch.  The role of phagocytes in virus infections. , 1961, Archivum immunologiae et therapiae experimentalis.

[79]  M. Kańtoch,et al.  Lytic activity of bacteriophages toward phagocytized bacteria. , 1960, Archivum immunologiae et therapiae experimentalis.